Anixa Biosciences, Inc. (ANIX)
4.75
-0.38
(-7.41%)
USD |
NASDAQ |
Dec 11, 16:00
5.49
+0.74
(+15.58%)
After-Hours: 18:06
Anixa Biosciences Total Liabilities (Quarterly): 2.24M for July 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 9.212B |
| Puma Biotechnology, Inc. | 87.59M |
| GT Biopharma, Inc. | 1.321M |
| ImmunityBio, Inc. | 1.042B |
| Lexeo Therapeutics, Inc. | 23.01M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 17.65M |
| Shareholders Equity (Quarterly) | 16.60M |
| Debt to Equity Ratio | 0.0128 |
| Current Ratio | 8.446 |
| Net Debt Paydown Yield | -0.01% |